Italika

I talk what I think and encourage other people to talk too.

[Italika @Usaval99]

New Stable Coin + Interest = New Fintech ! Already valued near $500M USD, accredited by the government of Bahrain ! ! ! LOTS OF CASH #NVDA #TSLA $PLTR #AMC $GME #SPCX $SPCX $ACM $GME $AMZN $TSLA

[Italika @Usaval99]

$AXG is getting huge traction

[Italika @Usaval99]

https://t.co/dmUSbQPl2B

[Italika @Usaval99]

A Test That Sees Cancer Before You Feel It https://t.co/rhtt6BF5wl via @YouTube

[Italika @Usaval99]

The Most Underrated Cancer Test in America? https://t.co/rZJiMFkwRo via @YouTube

[Italika @Usaval99]

This Test Could Catch Cancer Before It Starts 😳 https://t.co/58n44QoE7D via @YouTube

[Italika @Usaval99]

its going strong
https://t.co/W4IVlNR0w2

[Italika @Usaval99]

THis compamy is about to grow 160% https://t.co/4LNvIsNVRg

[Italika @Usaval99]

this german Company is Huge in the USA https://t.co/4LNvIsNVRg

[Italika @Usaval99]

https://t.co/cJEbF6nha1

[Italika @Usaval99]

Absolutely gigantic leap for colorectal cancer industry, now we know that $MYNZ is a 1000% legit company backed by $TMO 40B no 1 global leader, this stock will be worth 50x its time load it up $GME $AMC $TSLA $NVDA

[Italika @Usaval99]

$TRUMP FOREVER $MYNZ $GME $TSLA $PLTR

[Italika @Usaval99]

@yoha_santi 📊 $ONEMETA Setup: Potential 300%+ Breakout! 🚀

🔹 Current Price: $0.4340
🔹 Breakout Target: $1.64 📈
🔹 Resistance Levels: $0.70 - $0.80
🔹 Support: $0.43
A symmetrical triangle is forming—historically a strong signal for a major move! Volume tightening, breakout imminent.

[Italika @Usaval99]

this stock will fly https://t.co/TN1oMcHcJ2

[Petra Starke @StarkePetra]

March is Colorectal Cancer Awareness Month - It’s Time to Talk Prevention, Not Just Screening

I am so proud to be a Brand Ambassador.

I grew up in Europe, modeled in my teens, and I exercised nearly every day, got into yoga, became a vegetarian and am really honored to promote the health benefits of Mainz Biomed.

I work with Mainz Biomed because NO ONE should have to miss doing a Colectoral Screening Test. Mainz Biomed is at the cutting edge of allowing women, Mothers, and men the chance to positively change their lives.

Nobody should have to miss the chance for early detection... 🙏 🙏 🙏

💡 The truth about CRC screening today

Most available public tests only detect 42% or even as low as 20% of pre-cancer cases. That’s not even a coin flip.
CRC is the second leading cause of cancer deaths worldwide, yet more than 50% of cases could be prevented with early detection.
The U.S. healthcare system told me I was "too young" for a colonoscopy at 45. If I had waited, I wouldn’t be here.

💡 Prevention, not just detection

Mainz Biomed’s ColoAlert®️ is already in 10 labs, reaching 80 million patients in Europe—and expansion is happening NOW.
DNA buffer technology is changing the game. It allows retesting of the same sample, eliminating false results, reducing unnecessary colonoscopies, and getting us closer to 100% accuracy.
88% advanced adenoma detection—and we won’t stop until we reach 100%. Because certainty is the only way to truly beat cancer.

A huge thank you to Quest Diagnostics and Thermo Fisher Scientific for helping us make this happen. Their expertise in diagnostics and molecular technology is accelerating ColoAlert®️'s expansion and next-gen development, bringing us closer to early, accurate colorectal cancer detection for all.

💡 What’s next?

BIG updates are coming. More partnerships, more labs, and yes—FDA resubmission is on the horizon.
The U.S. market is next. And it’s happening fast.
This is not just a business. This is not just another test. This is about saving lives.

If you’re reading this, please listen to me. Don’t wait. Get tested. Take control.

No one should have to go through what I went through. And with the right tools, one day, they won’t have to.

#FDASubmission #CancerDetection #ColoAlert #Partnerships #Colonoscopy #Pfizer #GameChanger #Moderna #Cancer #ThisIsPersonal #USExpansion #SavingLives #StayTuned #CRC $CancerAwarness #Family #MyLife $MYNZ $DGX $TMO

[Italika @Usaval99]

https://t.co/TN1oMcHcJ2

[Italika @Usaval99]

https://t.co/TN1oMcHcJ2

[Petra Starke @StarkePetra]

March is Colorectal Cancer Awareness Month - It’s Time to Talk Prevention, Not Just Screening

I am so proud to be a Brand Ambassador.

I grew up in Europe, modeled in my teens, and I exercised nearly every day, got into yoga, became a vegetarian and am really honored to promote the health benefits of Mainz Biomed.

I work with Mainz Biomed because NO ONE should have to miss doing a Colectoral Screening Test. Mainz Biomed is at the cutting edge of allowing women, Mothers, and men the chance to positively change their lives.

Nobody should have to miss the chance for early detection... 🙏 🙏 🙏

💡 The truth about CRC screening today

Most available public tests only detect 42% or even as low as 20% of pre-cancer cases. That’s not even a coin flip.
CRC is the second leading cause of cancer deaths worldwide, yet more than 50% of cases could be prevented with early detection.
The U.S. healthcare system told me I was "too young" for a colonoscopy at 45. If I had waited, I wouldn’t be here.

💡 Prevention, not just detection

Mainz Biomed’s ColoAlert®️ is already in 10 labs, reaching 80 million patients in Europe—and expansion is happening NOW.
DNA buffer technology is changing the game. It allows retesting of the same sample, eliminating false results, reducing unnecessary colonoscopies, and getting us closer to 100% accuracy.
88% advanced adenoma detection—and we won’t stop until we reach 100%. Because certainty is the only way to truly beat cancer.

A huge thank you to Quest Diagnostics and Thermo Fisher Scientific for helping us make this happen. Their expertise in diagnostics and molecular technology is accelerating ColoAlert®️'s expansion and next-gen development, bringing us closer to early, accurate colorectal cancer detection for all.

💡 What’s next?

BIG updates are coming. More partnerships, more labs, and yes—FDA resubmission is on the horizon.
The U.S. market is next. And it’s happening fast.
This is not just a business. This is not just another test. This is about saving lives.

If you’re reading this, please listen to me. Don’t wait. Get tested. Take control.

No one should have to go through what I went through. And with the right tools, one day, they won’t have to.

#FDASubmission #CancerDetection #ColoAlert #Partnerships #Colonoscopy #Pfizer #GameChanger #Moderna #Cancer #ThisIsPersonal #USExpansion #SavingLives #StayTuned #CRC $CancerAwarness #Family #MyLife $MYNZ $DGX $TMO

[Italika @Usaval99]

This is huge #ColorectalCancerAwarenessMonth @TheEconomist @WSJ @RockstarGames @NewYorker @WhiteHouse45 @HuffPost https://t.co/TN1oMcHcJ2

[Petra Starke @StarkePetra]

March is Colorectal Cancer Awareness Month - It’s Time to Talk Prevention, Not Just Screening

I am so proud to be a Brand Ambassador.

I grew up in Europe, modeled in my teens, and I exercised nearly every day, got into yoga, became a vegetarian and am really honored to promote the health benefits of Mainz Biomed.

I work with Mainz Biomed because NO ONE should have to miss doing a Colectoral Screening Test. Mainz Biomed is at the cutting edge of allowing women, Mothers, and men the chance to positively change their lives.

Nobody should have to miss the chance for early detection... 🙏 🙏 🙏

💡 The truth about CRC screening today

Most available public tests only detect 42% or even as low as 20% of pre-cancer cases. That’s not even a coin flip.
CRC is the second leading cause of cancer deaths worldwide, yet more than 50% of cases could be prevented with early detection.
The U.S. healthcare system told me I was "too young" for a colonoscopy at 45. If I had waited, I wouldn’t be here.

💡 Prevention, not just detection

Mainz Biomed’s ColoAlert®️ is already in 10 labs, reaching 80 million patients in Europe—and expansion is happening NOW.
DNA buffer technology is changing the game. It allows retesting of the same sample, eliminating false results, reducing unnecessary colonoscopies, and getting us closer to 100% accuracy.
88% advanced adenoma detection—and we won’t stop until we reach 100%. Because certainty is the only way to truly beat cancer.

A huge thank you to Quest Diagnostics and Thermo Fisher Scientific for helping us make this happen. Their expertise in diagnostics and molecular technology is accelerating ColoAlert®️'s expansion and next-gen development, bringing us closer to early, accurate colorectal cancer detection for all.

💡 What’s next?

BIG updates are coming. More partnerships, more labs, and yes—FDA resubmission is on the horizon.
The U.S. market is next. And it’s happening fast.
This is not just a business. This is not just another test. This is about saving lives.

If you’re reading this, please listen to me. Don’t wait. Get tested. Take control.

No one should have to go through what I went through. And with the right tools, one day, they won’t have to.

#FDASubmission #CancerDetection #ColoAlert #Partnerships #Colonoscopy #Pfizer #GameChanger #Moderna #Cancer #ThisIsPersonal #USExpansion #SavingLives #StayTuned #CRC $CancerAwarness #Family #MyLife $MYNZ $DGX $TMO

[Petra Starke @StarkePetra]

March is Colorectal Cancer Awareness Month - It’s Time to Talk Prevention, Not Just Screening

I am so proud to be a Brand Ambassador.

I grew up in Europe, modeled in my teens, and I exercised nearly every day, got into yoga, became a vegetarian and am really honored to promote the health benefits of Mainz Biomed.

I work with Mainz Biomed because NO ONE should have to miss doing a Colectoral Screening Test. Mainz Biomed is at the cutting edge of allowing women, Mothers, and men the chance to positively change their lives.

Nobody should have to miss the chance for early detection... 🙏 🙏 🙏

💡 The truth about CRC screening today

Most available public tests only detect 42% or even as low as 20% of pre-cancer cases. That’s not even a coin flip.
CRC is the second leading cause of cancer deaths worldwide, yet more than 50% of cases could be prevented with early detection.
The U.S. healthcare system told me I was "too young" for a colonoscopy at 45. If I had waited, I wouldn’t be here.

💡 Prevention, not just detection

Mainz Biomed’s ColoAlert®️ is already in 10 labs, reaching 80 million patients in Europe—and expansion is happening NOW.
DNA buffer technology is changing the game. It allows retesting of the same sample, eliminating false results, reducing unnecessary colonoscopies, and getting us closer to 100% accuracy.
88% advanced adenoma detection—and we won’t stop until we reach 100%. Because certainty is the only way to truly beat cancer.

A huge thank you to Quest Diagnostics and Thermo Fisher Scientific for helping us make this happen. Their expertise in diagnostics and molecular technology is accelerating ColoAlert®️'s expansion and next-gen development, bringing us closer to early, accurate colorectal cancer detection for all.

💡 What’s next?

BIG updates are coming. More partnerships, more labs, and yes—FDA resubmission is on the horizon.
The U.S. market is next. And it’s happening fast.
This is not just a business. This is not just another test. This is about saving lives.

If you’re reading this, please listen to me. Don’t wait. Get tested. Take control.

No one should have to go through what I went through. And with the right tools, one day, they won’t have to.

#FDASubmission #CancerDetection #ColoAlert #Partnerships #Colonoscopy #Pfizer #GameChanger #Moderna #Cancer #ThisIsPersonal #USExpansion #SavingLives #StayTuned #CRC $CancerAwarness #Family #MyLife $MYNZ $DGX $TMO

[Italika @Usaval99]

#ColorectalCancerAwarenessMonth and this company will change it all

[Science Magazine @ScienceMagazine]

Early-onset colorectal cancer is expected to become the leading cause of #cancer death in ages 20 to 49 in the U.S. by 2030.

Research is urgently needed to better detect and treat patients, argues this #SciencePerspective: https://t.co/3hkt8o9YZE #ColorectalCancerAwarenessMonth